Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

News You Need to Know Today
News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk
Tuesday, April 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

READ MORE >
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
Share on Twitter Share on Facebook Share on Linkedin

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

News Alert: Medtronic announces $550M acquisition
Looking ahead to ACC.26 | Oversizing during TAVR boosts survival | Next-generation device delivers | AATS wants better research
Cardiology still a leader in AI | FDA details catheter recall | A key approval for Philips | Potential new gene therapies
Week in Review: FDA approves next-generation device | More recalls for Impella heart pumps | CMS targets cardiologists
News Alert: FDA warns public about reprocessed catheter recalls
World’s first polymeric TAVR valve | Cardiologists develop new AI tool | High-sensitivity troponin | Heart issues in infants
Experimental pill could be a game-changer | Device error linked to 114 injuries | Statin labels need an update | A $1M donation

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …18
    • Page 19
    • Page 20
    • Page 21
    • Current page 22
    • Page 23
    • Page 24
    • Page 25
    • Page 26 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme